New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease

New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease

Aim. To evaluate the relationship between albumin to creatinine ratio (ACR) in a single and 24-hours urine spots and chronic kidney disease (CKD) progression pace in patients with atrial fibrillation, CKD and diabetes mellitus.Material and methods. 60 patients with atrial fibrillation (AF) and CKD w...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2021-07-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	albumin to creatinine ratio chronic kidney disease atrial fibrillation diabetes mellitus albuminuria
Online Access:	https://www.rpcardio.online/jour/article/view/2499
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Changes of the level of galectin-3, β-2-microglobulin, albuminuria and end glycation products in patients with chronic heart failure and atrial fibrillation under the influence of treatment.
by: O. V. Kuryata, et al.
Published: (2018-06-01)

Changes of the level of galectin-3, β-2-microglobulin, albuminuria and end glycation products in patients with chronic heart failure and atrial fibrillation under the influence of treatment
by: Kuryata O.V., et al.
Published: (2018-05-01)

Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy
by: D. A. Napalkov, et al.
Published: (2019-09-01)

Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01)

New prospects for assessing the hemostasis system in atrial fibrillation and left atrial appendage thrombosis
by: Z. A. Gebekova, et al.
Published: (2023-01-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)

Laboratory predictors of clinical outcomes in patients with atrial fibrillation
by: A. A. Sokolova, et al.
Published: (2021-05-01)

Prevalence of Diabetic Nephropathy in Patients with Type Two Diabetes Mellitus: A Cross-Sectional Study
by: Brusk Tariq Fars, et al.
Published: (2025-06-01)

A POSSIBILITY TO USE ANTIARRHYTHMIC MEDICATIONS FROM II CLASS AND MODULATED KINESITHERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN METABOLIC SYNDROME PATIENTS
by: A. I. Olesin, et al.
Published: (2015-11-01)

Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable
by: D. A. Napalkov, et al.
Published: (2018-11-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

Cryptogenic stroke in atrial fibrillation without intra-heart thrombi: possible mechanisms
by: O. A. Germanova, et al.
Published: (2022-05-01)

Current Predictors of Atrial Fibrillation Progression
by: V. I. Podzolkov, et al.
Published: (2019-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Telocytes and Atrial Fibrillation: From Basic Research to Clinical Practice
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY
by: A. I. Olesin, et al.
Published: (2014-12-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis
by: A. A. Sokolova, et al.
Published: (2022-07-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
by: E V Schlyakhto, et al.
Published: (2022-01-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data
by: A. I. Listratov, et al.
Published: (2024-10-01)

Inotropic myocardial function dynamics in patients with recurrent atrial fibrillation
by: N. E. Gaidamakina, et al.
Published: (2006-06-01)

Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
by: V. I. Podzolkov, et al.
Published: (2018-08-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
by: A. А. Sokolova, et al.
Published: (2017-12-01)

Inflammation and Nutritional Status Mediated the Increased of Risk of Atrial Fibrillation Recurrence Associated with eGFRdiff Post-Ablation
by: Huang W, et al.
Published: (2024-11-01)

CLINICAL AND STATISTICAL EVALUATION OF THE CALLS OF PATIENTS WITH ATRIAL FIBRILLATION
by: N. F. Plavunov, et al.
Published: (2018-10-01)

The association between the cystatin C- and creatinine-based estimated GFR ratio and post-ablation outcomes in patients with atrial fibrillation
by: Wenchao Huang, et al.
Published: (2025-12-01)

Marfanoid appearance as a risk factor for atrial fibrillation in patients with osteoporosis
by: I. A. Zolotovskaya, et al.
Published: (2016-06-01)

ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION?
by: D. A. Napalkov, et al.
Published: (2016-05-01)